At the lab of Dr. Adriana Di Polo at University of Montreal, researchers are paving the way for the development of therapeutic approaches to protect pericytes and their nanotubes. The goal? Restoring vascular health and vision in glaucoma. In living animals, as in humans, the retina uses the oxygen and nutrients contained in the blood to function … Continue reading "Glaucoma: Seeing the Light at the End of the (Nano)Tunnel”"
This video is from our March 15th Zoom where Dr. Louis Pasquale discussed how artificial intelligence will impact glaucoma prevention and treatment. Primary open-angle glaucoma (POAG) is a disease subtype defined by chronic, progressive, and irreversible retinal ganglion cell (RGC) loss without clinically evident causes for either elevated intraocular pressure (IOP) or optic nerve degeneration. … Continue reading "Using Artificial Intelligence to Disentangle Glaucoma Pathogenesis"
Therapies for Glaucoma are safer, more effective, and more tailored to the patient’s needs than ever before. In this webinar we discussed updates in Surgical Technologies, Drugs and New Drug Delivery, New Lasers, and what is just around the corner. Together let’s shed light on glaucoma therapies to help stop tunnel vision.
We would like to say thank you to everyone that supported our 40th Anniversary Gala. Your generous contributions helped us raise $561,000 and we are truly grateful. Enjoy the recap video and pictures from the event below. You can also click here to see more videos from the event on our YouTube channel. Click for More … Continue reading "TGF’s 40th Anniversary Gala"
Dr. Calvin Roberts discusses the ARPA-H program, THEA, Transplantation of Human Eye Allografts. This national program aims to bring together the expertise of vision scientists from multiple universities and laboratories to restore vision to those who are blind, by transplanting a donor eye. Recent advances in regenerative medicine and biomaterials may allow the functional reconnection … Continue reading "Webinar – Restoring Vision: Making Whole Eye Transplantation a Reality"
We had a panel of low-vision specialists and patient advocates talk about a range of techniques and assets you can use to improve your home and work-life. From simple low-tech methods and products to advanced optical and electronic technologies.
https://youtu.be/Q1iXTqktFS0 https://youtu.be/P6Xlb7JpVO4 https://youtu.be/gH2IRyxs0As https://youtu.be/crvlQCK1vaM https://youtu.be/h-w9rYg6e7o https://youtu.be/e6Zavc_V3g8 https://youtu.be/V3I6b1FZxzM https://youtu.be/lIh-xO8ZSyY https://youtu.be/6x60VqQ5nyI https://youtu.be/lelGVCi4jZM https://youtu.be/NCiy833ttVg https://youtu.be/dUd-foy7DNY
"Harnessing Artificial Intelligence to Improve Glaucoma Management: Challenges & Opportunities" How will artificial intelligence improve glaucoma care? How can AI support clinicians in the treatment of their glaucoma patients? What are the challenges in implementing appropriate AI systems in clinical practice? This webinar will provide basic information about artificial intelligence (AI) in ophthalmology, and an … Continue reading "Harnessing Artificial Intelligence to Improve Glaucoma Management: Challenges & Opportunities"
The Glaucoma Foundation invites you to a fireside video chat with Mark Lesselroth and Dr. George Spaeth who delve into some of the common misconceptions about glaucoma and how patients can take control of their health. We will be following up on this conversation with a written Q&A in the September issue of our e- … Continue reading "A Fireside Chat With Dr. George Spaeth & Mark Lesselroth"
The Johnson Laboratory at the Johns Hopkins Wilmer Eye Institute has spent the past 5 years working to develop stem cell therapies capable of regenerating the optic nerve and restoring vision for patients suffering from glaucoma. This is a challenging goal since it requires the replacement of lost nerve cells in the eye and … Continue reading "Building Connections: Research Progress in Vision-Restoring Therapy for Glaucoma"
Janey L. Wiggs, M.D., Ph.D. is a physician-scientist at the Massachusetts Eye and Ear Infirmary and Harvard Medical School. She is currently the Paul Austin Chandler Professor of Ophthalmology at Harvard Medical School and is the Vice Chair for Clinical Research in Ophthalmology at the Massachusetts Eye and Ear Infirmary. She also directs the CLIA-certified … Continue reading "Webinar – The Role of Genetics in Glaucoma Diagnosis & Prevention"
Glaucoma is the leading cause of irreversible blindness worldwide. 59% of glaucoma patients are female; therefore, it is worthwhile to understand if there are associations between female reproductive factors and glaucoma. Dr. Andrew Feola’s group focuses on understanding how menopause and estrogen play a role in risk factors related to the onset of glaucoma and … Continue reading "Insights into Glaucoma and Women’s Health: Exploring the Impact of Menopause and Visual Function"
